Ling Xue
About Ling Xue
Ling Xue is the Chief of Staff and Head of Portfolio Management at BeiGene in Beijing, with extensive experience in oncology clinical trials and biomarker discovery.
Current Role at BeiGene
Ling Xue currently serves as the Chief of Staff and Head of Portfolio Management at BeiGene in Beijing. In this role, she oversees the management and execution of the company's diverse portfolio, ensuring strategic alignment with business objectives. Her responsibilities include coordinating between various departments and optimizing project management practices to enhance efficiency and productivity.
Previous Positions at BeiGene
Before her current role, Ling Xue held several key positions at BeiGene. She was the Director of Clinical Development from 2016 to 2017. Prior to that, she served as Associate Director of Clinical Development from 2015 to 2016 and Senior Principal Clinical Scientist in 2015. During her tenure, she contributed to the design and execution of early-stage oncology clinical trials and pivotal trials, utilizing her extensive experience and expertise in trial design and execution.
Experience at Pharmacyclics and BioGenex
Ling Xue's professional journey includes her roles at Pharmacyclics, where she worked as Scientist III from 2013 to 2015 and Scientist II in 2013. She also served as Senior Scientist at BioGenex from 2011 to 2013. In these roles, she specialized in target biomarker discovery and development, focusing on identification, validation, assay development, mechanism of action studies, high throughput/content screening, and cell signaling studies.
Academic Background
Ling Xue holds a Ph.D. in Cancer Biology from the University of California, Berkeley, where she studied from 2000 to 2004. She earned her M.S. and B.S. in Biochemistry and Molecular Biology from Nankai University, completing her studies in 2000 and 1997, respectively. Her strong academic foundation has been instrumental in her successful career in clinical development and biomarker discovery.
Research and Publications
Throughout her career, Ling Xue has maintained an extensive record of publishing in peer-reviewed journals and presenting at international conferences. Her research findings and presentations reflect her deep knowledge and expertise in the fields of oncology, biochemistry, and molecular biology. She has also demonstrated the ability to establish and coordinate large multi-disciplinary collaborations in academia and the biotechnology industry.